Tecartus

Generic name:brexucabtagene autoleucel [ BREX-ue-KAB-ta-jeen-AH-toe-LOO-sel ]
Drug class:Miscellaneous antineoplastics

Medically reviewed by Judith Stewart, BPharm. Last updated on Oct 4, 2021.

What is Tecartus?

Tecartus is a genetically modified T cell immunotherapy medicine.

Tecartus is used to treat mantle cell lymphoma in adults. 

Tecartus is also used to treat acute lymphoblastic leukemia in adults.

Tecartus is made using white blood cells removed from blood that is drawn from your body through a vein.

This medicine is given after other treatments did not work or have stopped working.

Warnings

A common but serious side effect of Tecartus is called cytokine release syndrome, which causes fever, chills, trouble breathing, vomiting, and other symptoms. Your caregivers will have medication available to quickly treat this condition if it occurs.

It is important to tell your healthcare provider that you received Tecartus and to show them your Tecartus Patient Wallet Card. Your healthcare provider may give you other medicines to treat your side effects.

Before taking this medicine

You should not be treated with Tecartus while you have an active infection (such as fever, chills, flu-like symptoms).

To make sure Tecartus is safe for you, tell your doctor if you have ever had::

• an active or chronic infection;

• a stroke;

• a seizure;

• memory problems;

• breathing problems;

• hepatitis B or C;

• HIV;

• heart problems;

• liver disease;

• kidney...